Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Imunon Inc (NASDAQ: IMNN) was $2.27 for the day, up 95.69% from the previous closing price of $1.16. In other words, the price has increased by $95.69 from its previous closing price. On the day, 96.51 million shares were traded.
Ratios:
Our analysis of IMNN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.88. In the meantime, Its Debt-to-Equity ratio is 2.24 whereas as Long-Term Debt/Eq ratio is at 1.36.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 20 ’24 when Braun Donald P bought 25,000 shares for $1.18 per share. The transaction valued at 29,480 led to the insider holds 25,597 shares of the business.
Lindborg Stacy bought 25,000 shares of IMNN for $24,500 on Aug 15 ’24. The President and CEO now owns 264,166 shares after completing the transaction at $0.98 per share. On Aug 15 ’24, another insider, Tardugno Michael H, who serves as the Executive Chairman of Board of the company, bought 25,000 shares for $1.03 each. As a result, the insider paid 25,750 and bolstered with 353,346 shares of the company.
Stock Price History:
Over the past 52 weeks, IMNN has reached a high of $3.65, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 158.00%, while the 200-Day Moving Average is calculated to be 144.58%.
Shares Statistics:
A total of 17.54M shares are outstanding, with a floating share count of 16.68M. Insiders hold about 4.89% of the company’s shares, while institutions hold 9.08% stake in the company.
Earnings Estimates
The market rating of Imunon Inc (IMNN) is currently shaped by the ongoing analysis conducted by 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.13 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.14 and -$1.24 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$0.92, with 4.0 analysts recommending between -$0.36 and -$1.4.
